Globe and Mail- Spurring Growth in Canada’s life sciences sector

Writer: GLENN LOWSON/THE GLOBE AND MAIL

Close to 300 people gathered at The Globe and Mail Centre on November 14 to join a conversation on growth strategies for the Canadian biomedical sector.

Speakers agreed Canada punches above its weight in early-stage research and clinical trials but has yet to produce a home-grown, large-scale life sciences company.

“We’re investing in this early stage research. Where are the outputs? Where is our BlackBerry of biotech?” asked Jason Field, president of Life Sciences Ontario.

Read the full Globe and Mail article here.